Do salt cravings in children with autistic disorders reveal low blood sodium depleting brain taurine and glutamine?

Medical Hypotheses

Volumn 77, Issue 6, 2011, Pages 1015-1021

  Good, Peter ^a  

^a Autism Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ARGININE; GLUTAMINE; INOSITOL; MAGNESIUM; PRASTERONE; SODIUM; TAURINE; TESTOSTERONE; VASOPRESSIN;

ANTERIOR CINGULATE; ARTICLE; ASTROCYTE; AUTISM; BRAIN; BRAIN CORTEX; BRAIN DISEASE; CELL PROLIFERATION; CEREBELLUM; GASTROENTERITIS; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOGLYCEMIA; HYPONATREMIA; INNATE IMMUNITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMA; SALT INTAKE; SEIZURE; SODIUM BLOOD LEVEL; THROMBOCYTE; WATER INTOXICATION;

ASTROCYTES; AUTISTIC DISORDER; BRAIN; FEMALE; GLUTAMINE; HUMANS; HYPONATREMIA; MALE; MODELS, BIOLOGICAL; SODIUM, DIETARY; TAURINE; VASOPRESSINS;

EID: 80755153762     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.038     Document Type: Article

References (88)

1. Herbert M. The future of autism research. Keynote address at the Autism Society's 40th National Conference on Autism Spectrum Disorders, July 23, 2009. http://www.youtube.com/watch?v=nm2YbgziYwc (Accessed 7/3/11).
2. Pangborn JB. Personal communication 2010.
3. Cohen B.I. Infantile autism and the liver: a possible connection. Autism 2000, 4:441-442.
4. Filipek P.A., Juranek J., Nguyen M.T., Cummings C., Gargus J.J. Relative carnitine deficiency in autism. J Autism Dev Disord 2004, 34:615-623.
5. Wakefield A.J., Puleston J.M., Montgomery S.M., Anthony A., O'Leary J.J., Murch S.H. Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther 2002, 16:663-674.
6. Williams R. Review article: bacterial flora and pathogenesis in hepatic encephalopathy. Aliment Pharmacol Ther 2006, 25(Supp 1):17-22.
7. Milner J.A. Metabolic aberrations associated with arginine deficiency. J Nutr 1985, 115:516-523.
8. Brusilow S.W., Koehler R.C., Traystman R.J., Cooper A.J. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 2010, 7:452-470.
9. Benarroch E.E. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 2005, 80:1326-1338.
10. Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog Neurobiol 2002, 67:259-279.
11. Córdoba J., García-Martinez R., Simón-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis 2010, 25:73-80.
12. Krivitzky L., Babikian T., Lee H.S., Thomas N.H., Burk-Paull K.L., Batshaw M.L. Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Pediatr Res 2009, 66:96-101.
13. Anonymous MD. Personal communication 2011.
14. Görker I., Tüzün U. Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl. J Psychiatry Neurosci 2005, 30:133-135.
15. Anthony A., Waring R., Murch S.H., Wakefield A.J. Glutamine and glutamate:glutamine ratios in children with regressive autism and entero-colitis: preliminary evidence for an entero-colonic encephalopathy. Gastroenterology 2001, 120(Suppl.):A726. [abstract only].
16. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67-81.
17. Aschner M., Allen J.W., Kimelberg H.K., LoPachin R.M., Streit W.J. Glial cells in neurotoxicity development. Annu Rev Pharmacol Toxicol 1999, 39:151-173.
18. Lonsdale D., Shamberger R.J., Audhya T. Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. Neuro Endocrinol Lett 2002, 23:303-308.
19. Massieu L., Montiel T., Robles G., Quesada O. Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies. Neurochem Res 2004, 29:73-81.
20. Horvath K., Perman J.A. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 2002, 4:251-258.
21. Momeni N., Nordström B.M., Horstmann V., Avarseji H., Sivberg B.V. Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders. BMC Psychiatry 2005, 5:27-32.
22. Hussy N., Brès V., Rochette M., et al. Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine. J Neurosci 2001, 21:7110-7116.
23. Rolf L.H., Haarmann F.Y., Grotemeyer K.H., Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 1993, 87:312-316.
24. Moreno-Fuenmayor H., Borjas L., Arrieta A., Valera V., Socorro-Candanoza L. Plasma excitatory amino acids in autism. Invest Clin 1996, 37:113-128.
25. Zavala M., Castejón H.V., Ortega P.A., Castejón O.J., Marcano de Hidalgo A., Montiel N. Imbalance of plasma amino acids in patients with autism and subjects with attention deficit/hyperactivity disorder [article in Spanish, English abstract]. Rev Neurol 2001, 33:401-408.
26. Aldred S., Moore K.M., Fitzgerald M., Waring R.H. Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 2003, 33:93-97.
27. Tirouvanziam R, Obukhanych TV, Laval J, et al. Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with autism spectrum disorders. J Autism Dev Disord 2011. [Epub ahead of print].
28. Bode B.P. Recent molecular advances in mammalian glutamine transport. J Nutr 2001, 131:2475S-2485S.
29. Stelmashook EV, Isaev NK, Lozier ER, Goryacheva ES, Khaspekov LG. Role of glutamine in neuronal survival and death during brain ischemia and hypoglycemia. Int J Neuroscience 2011. [Epub ahead of print].
30. Souba W.W. Glutamine: a key substrate for the splanchnic bed. Ann Rev Nutrit 1991, 11:285-308.
31. Brosnan J.T. Interorgan amino acid transport and its regulation. J Nutr 2003, 133:2068S-2072S.
32. DeVito T.J., Drost D.J., Neufeld R.W., et al. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 2007, 61(4):465-473.
33. Bernardi S., Anagnostou E., Shen J., et al. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res 2011, 1380:198-205.
34. Page L.A., Daly E., Schmitz N., et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006, 163:2189-2192.
35. Autism Research Institute. Parent ratings of behavioral effects of biomedical interventions. http://www.autism.com/treatable/form34qr.htm (Accessed 12/4/10).
36. Quincozes-Santos A., Bobermin L.D., Kleinkauf-Rocha J., et al. Atypical neuroleptic risperidone modulates glial functions in C6 astroglial cells. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:11-15.
37. Lumsden C.E. Pathogenetic mechanisms in the leucoencephalopathies, in anoxic-ischaemic processes, in disorders of the blood and in intoxications. Handbook of Clinical Neurology v. 9 1970, 572-663. American Elsevier, New York. G.W. Vinken, P.J. Bruyn (Eds.).
38. Gabis L., Huang Wei., Azizian A., et al. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. J Child Neurol 2008, 23:766-774.
39. Carter C.S. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?. Behav Brain Res 2007, 176:170-186.
40. Moritz M.L., Ayus J.C. New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol 2010, 25:1225-1238.
41. Heins J., Zwingmann C. Organic osmolytes in hyponatremia and ammonia toxicity. Metab Brain Dis 2010, 25:81-89.
42. Courchesne E., Carper R., Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003, 290:337-344.
43. Baron-Cohen S., Knickmeyer R.C., Belmonte M.K. Sex differences in the brain: implications for explaining autism. Science 2005, 310:819-823.
44. Geier D.A., Geier M.R. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm Res 2006, 66:182-188.
45. Barker E.V., Hume R., Hallas A., Coughtrie W.H. Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinol 1994, 134:982-989.
46. Good P. Did acetaminophen provoke the autism epidemic?. Altern Med Rev 2009, 13:364-372.
47. Harony H., Wagner S. The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder. Neurosignals 2010, 18:82-97.
48. Neville K.A., Verge C.F., O'Meara M.W., Walker J.L. High antidiuretic hormone levels and hyponatremia in children with gastroenteritis. Pediatrics 2005, 116:1401-1407.
49. Emanuele E. Autism conceptualized as a vasopressin resistance syndrome. Med Hypotheses 2006, 66:1245.
50. Koide H. Three cases of hyponatremia during administration of pimozide [Article in Japanese, English abstract]. No To Hattatsu 1991, 23:502-505.
51. Hiratani M., Munesue T., Terai K., Haruki S. Two cases of infantile autism with intermittent water intoxication due to compulsive water drinking and episodic release of antidiuretic hormone (SIADH) [Article in Japanese, English abstract]. No To Hattatsu 1997, 29:367-372.
52. Moritz M.L., Ayus J.C. Hyponatremia in preterm neonates: not a benign condition. Pediatrics 2009, 124:1014-1016.
53. Web MD. Unusual salt craving. http://forums.webmd.com/3/autism-support-exchange/forum/32 (Accessed 7/3/11).
54. Autism Blogger. Salt cravings. http://www.autism-blog.com/salt-cravings (Accessed 7/3/11).
55. De Luca L.A., Vendramini R.C., Pereira D.T., et al. Water deprivation and the double-depletion hypothesis: common neural mechanisms underlie thirst and salt appetite. Braz J Med Biol Res 2007, 40:707-712.
56. Morris M.J., Na E.S., Johnson A.K. Salt craving: the psychobiology of pathogenic sodium intake. Physiol Behav 2008, 94:709-721.
57. Beauchamp G.K., Bertino M., Moran M. Sodium regulation: sensory aspects. J Am Diet Assoc 1982, 80:40-45.
58. Córdoba J., Gottstein J., Blei A.T. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 1998, 29:589-594.
59. Pangborn JB. Introduction to the diseases of autism and laboratory testing options. In: Pangborn JB, Baker SM. Biomedical Assessment Options for Children with Autism and Related Problems. San Diego, CA: Autism Research Institute; 2002. p. 1-130.
60. Albrecht J., Sonnewald U., Waagepetersen H.S., Schousboe A. Glutamine in the central nervous system: function and dysfunction. Front Biosci 2007, 12:332-343.
61. Huxtable R.J. Expanding the circle 1975-1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 2000, 483:1-25.
62. Durlach J., Durlach V. Speculations on hormonal controls of magnesium homeostasis: a hypothesis. Magnesium 1984, 3:109-131.
63. Laidlaw S.A., Kopple J.D. Newer concepts of the indispensable amino acids. Am J Clin Nutr 1987, 46:593-605.
64. Awapara J. The metabolism of taurine in the animal. In: Huxtable R, Barbeau A, eds. Taurine. New York: Raven Press; 1976. 1-19.
65. Tanoue Y., Oda S. Weaning time of children with infantile autism. J Autism Dev Disord 1989, 19:425-434.
66. Schultz ST, Klonoff-Cohen HS, Wingard DL, et al. Breastfeeding, infant formula supplementation, and autistic disorder: the results of a parent survey. Int Breastfeed J 2006. http://www.internationalbreastfeedingjournal.com/content/1/1/16 (Accessed 5/23/10).
67. Autism Research Institute. Treatment Options for Mercury/Metal Toxicity in Autism and Related Developmental Disabilities: Consensus Position Paper. February 2005. http://www.autism.com/pdf/providers/heavymetals.pdf (Accessed 6/14/10).
68. Sweeten T.L., Posey D.J., Shankar S., McDougle C.J. High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry 2004, 55:434-437.
69. Carrick, Bob, Dee. The Use of Amino Acid Supplements with Autism and OCD. free pdf at: (Accessed 2/6/11). http://www.ozmofun.com/articles/amino_acids.pdf.
70. Helt M., Kelley E., Kinsbourne M., et al. Can children with autism recover? If so, how?. Neuropsychol Rev 2008, 18:339-366.
71. Good P. Letter in response to Helt et al. 2008. Does fever relieve autistic behavior by improving brain blood flow?. Neuropsychol Rev 2011, 21:66-67.
72. Wannemacher R.W., Pekarek R.W., Bartelloni P.J., Vollmer R.T., Beisel W.R. Changes in individual plasma amino acids following experimentally induced sand fly fever virus infection. Metabolism 1972, 21:67-76.
73. Norenberg M.D., Rao K.V., Jayakumar A.R. Mechanisms of ammonia-induced astrocyte swelling. Metab Brain Dis 2005, 20:303-318.
74. Solis-Herruzo J.A., Gonzalez-Gamarra A., Castellano G., Muñoz-Yagüe M.T. Metabolic clearance rate of arginine vasopressin in patients with cirrhosis. Hepatology 1992, 16:974-979.
75. Goodwin M.S., Groden J., Velicer W.F., et al. Cardiovascular arousal in individuals with autism. Focus Autism Other Dev Disabl 2006, 21:100-123.
76. Herbert MR. Treatment-guided research. Helping people now with humility, respect and boldness. Autism Advocate 2008:8-14.
77. Herbert M.R. SHANK3, the synapse, and autism. N Engl J Med 2011, 365:173-175.
78. Tisdall M., Crocker M., Watkiss J., Smith M. Disturbances of sodium in critically ill adult neurologic patients: a clinical review. J Neurosurg Anesthesiol 2006, 18:57-63.
79. Wu G., Bazer F.W., Davis T.A., et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009, 37:153-168.
80. Myers R.D., Veale W.L. Body temperature: possible ionic mechanism in the hypothalamus controlling the set point. Science 1970, 170:95-97.
81. Schultz S.T., Klonoff-Cohen H.S., Wingard D.L., et al. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism 2008, 12:293-307.
82. Fallon J. Could one of the most widely prescribed antibiotics amoxicillin/clavulanate "augmentin" be a risk factor for autism?. Med Hypotheses 2005, 64:312-315.
83. Greenberg D., Hoffman S., Leibovitz E., Dagan R. Acute otitis media in children: association with day care centers - antibacterial resistance, treatment, and prevention. Paediatr Drugs 2008, 10:75-83.
84. Adams J.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A. Gastrointestinal flora and gastrointestinal status in children with autism - comparisons to neurotypical children and correlation with autism severity. BMC Gastroenterol 2011, 11:22-34.
85. Collins J.K., Wu G., Perkins-Veazie P., et al. Watermelon consumption increases plasma arginine concentrations in adults. Nutrition 2007, 23:261-266.
86. Oral rehydration salts (ORS): earlier WHO formulation (more glucose, no artificial sweeteners) available at REI or Jianas Brothers () (Accessed 8/5/11). http://rehydrate.org/resources/jianas.htm.
87. present WHO formulation (less glucose, artificial sweeteners) available as HYDRAssist () (Accessed 8/5/11). http://www.sa-wellbeing.com.
88. Bardhan P.K. Improving the ORS: Does glutamine have a role?. J Health Popul Nutr 2007, 25:263-266.